StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Cantor Fitzgerald Reiterates Overweight Rating on TG Therapeutics (TGTX)
March 3, 2025 1:07 PM
Cantor Fitzgerald analyst Prakhar Agrawal reiterated an Overweight rating on TG Therapeutics (NASDAQ: TGTX).The analyst comments "TGTX stock is up ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Next Articles
Form 8-K TG THERAPEUTICS, INC. For: Mar 03
March 3, 2025 7:19 AM
TG Therapeutics (TGTX) Tops Q4 EPS by 7c, provides outlook
March 3, 2025 7:06 AM
TG Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results
March 3, 2025 7:00 AM
TG Therapeutics (TGTX) Announces Presentation of Data for BRIUMVI in Multiple Sclerosis at the Americas Committee for Treatment and Research in Multiple Sclerosis Annual Forum
February 27, 2025 7:32 AM
TG Therapeutics Announces Presentation of Data for BRIUMVI® in Multiple Sclerosis at the Americas Committee for Treatment and Research in Multiple Sclerosis Annual Forum
February 27, 2025 7:30 AM
